CBG/ CANNABIGEROL     phytocannabinoid, CB2 agonist

 

Phytocannabinoids                 (news – undated)

http://www.news-medical.net/health/Phytocannabinoids.aspx

 

Allergenic properties of naturally occurring cannabinoids.                (abst – 1983)

http://www.ncbi.nlm.nih.gov/pubmed/6620158

 

Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.                                         (abst – 1984)                 http://www.ncbi.nlm.nih.gov/pubmed/6499952

 

Identification of a New Chemotype in Cannabis sativa: Cannabigerol – Dominant Plants, Biogenetic and Agronomic Prospects                                                            (abst – 1987)

https://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-962705

 

The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation.                                                        (abst – 1989)  http://www.ncbi.nlm.nih.gov/pubmed/2575149

 

A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.            (abst – 1990)                          http://www.ncbi.nlm.nih.gov/pubmed/1965836

 

In vitro metabolism of cannabigerol in several mammalian species.              (abst – 1990)

http://www.ncbi.nlm.nih.gov/pubmed/2224182

 

Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells.                                                                (abst – 1998)  http://www.ncbi.nlm.nih.gov/pubmed/9875457

 

Cannabinoids in clinical practice.                (abst – 2000)

http://www.ncbi.nlm.nih.gov/pubmed/11152013

 

Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.   (full – 2008)  http://www.scribd.com/doc/7718968/Antibacterial-Cannabinoids-From-Cannabis-Sativa-A-  StructureActivity-Study

 

Patent application title: THERAPEUTIC USES OF CANNABIGEROL            (full – 2010)

http://www.faqs.org/patents/app/20100292345

 

Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.                                                      (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823359/?tool=pubmed

 

Antidepressant-like effect of Delta(9)-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.                                                                  (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed

 

Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.    (abst – 2010)                           http://www.ncbi.nlm.nih.gov/pubmed/20614687

 

Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full – 2011)  https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf

 

Phytocannabinoids for use in the treatment of cancer   – Patent  GB2478595  (A) ― 2011-09-14            (full – 2011)

http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=

&date=20110914&DB=&locale=en_EP

 

Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. (abst – 2011)                                          http://www.ncbi.nlm.nih.gov/pubmed/21243485

 

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive- compulsive behaviour.          (abst – 2011)                                                         http://www.ncbi.nlm.nih.gov/pubmed/21796370

 

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.                                                          (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21175579/abstract/Effects_of_cannabinoids_and_c  annabinoid_enriched_Cannabis_extracts_on_TRP_channels_and_endocannabinoid_metabolic_enzymes_

 

Phytocannabinoids as novel therapeutic agents in CNS disorders                    (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/21924288

 

A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.          (abst – 2012)                        http://www.ncbi.nlm.nih.gov/pubmed/22971837

 

Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR.                                                  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23280038

 

Share a link for